Sign In
Buy INO
$1.14
-0.0700 (-5.79%)
At Close: Jun 03, 2026
Inovio Pharmaceuticals (INO) Q2 2022 Earnings Call Transcript
04:01am, Wednesday, 10'th Aug 2022 The Motley Fool
INO earnings call for the period ending June 30, 2022.
Inovio Pharmaceuticals (INO) Reports Q2 Loss, Tops Revenue Estimates
11:25pm, Tuesday, 09'th Aug 2022 Zacks Investment Research
Inovio (INO) delivered earnings and revenue surprises of -53.33% and 264.65%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Inovio Pharmaceuticals (INO) Reports Q2 Loss, Tops Revenue Estimates
09:04pm, Tuesday, 09'th Aug 2022
Inovio (INO) delivered earnings and revenue surprises of -53.33% and 264.65%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Inovio Pharmaceuticals, Inc. (INO) CEO Jacqueline Shea on Q2 2022 Results - Earnings Call Transcript
08:30pm, Tuesday, 09'th Aug 2022
Inovio Pharmaceuticals, Inc. (NASDAQ:INO ) Q2 2022 Earnings Conference Call August 9, 2022 4:30 PM ET Company Participants Thomas Hong - IR Jacqueline Shea - CEO, President & Director Michael Sumner -
Two Appealing Biotech Stocks for Two Distinct investors
11:11am, Monday, 08'th Aug 2022
Investing in biotech stocks carries both risk and reward. This article highlights two biotech companies that may appeal to specific investing styles
Inovio Pharmaceuticals (INO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
02:00pm, Tuesday, 02'nd Aug 2022 Zacks Investment Research
Inovio (INO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
6 Stocks To Watch As The World Health Organization Declares Monkeypox Outbreak A Global Emergency
07:23pm, Sunday, 24'th Jul 2022 Benzinga
The World Health Organization (WHO) on Saturday declared the monkeypox outbreak a global emergency, its highest level of alert.
WHO Director-General Tedros Adhanom Ghebreyesus said more than 16,0
1 Beaten-Down Growth Stock To Avoid Like the Plague
11:40am, Sunday, 24'th Jul 2022 The Motley Fool
The last few years haven't been kind to Inovio Pharmaceuticals.
1 Beaten-Down Growth Stock To Avoid Like the Plague
07:40am, Sunday, 24'th Jul 2022
The last few years haven't been kind to Inovio Pharmaceuticals.
After Slashing Costs, Is Inovio a Buy?
10:30am, Friday, 22'nd Jul 2022 The Motley Fool
It's betting on success as a vaccine latecomer.
After Slashing Costs, Is Inovio a Buy?
06:30am, Friday, 22'nd Jul 2022
It's betting on success as a vaccine latecomer.
Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday
08:40am, Thursday, 21'st Jul 2022 Benzinga
Gainers
Pagaya Technologies Ltd. (NASDAQ: PGY) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.
Direct Digital Ho
This Communication Services Stock Is Trading Higher By Over 82%, Here Are 45 Stocks Moving In Wednesday's Mid-Day Session
04:50pm, Wednesday, 20'th Jul 2022 Benzinga
Gainers
Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 82.2% to $2.6787. Direct Digital Holdings said its supply-side advertising platform, Colossus SSP, reported a 540% year-over-year gr
RBC Capital Lowers Inovio Price Target As It Awaits This
07:14pm, Tuesday, 19'th Jul 2022 Benzinga
RBC Capital Markets has lowered the price target on Inovio Pharmaceuticals Inc (NASDAQ: INO) to $4 from $5 with a Sector Perform rating.
The analysts updated the model to reflect the evolution of
RBC Capital Lowers Inovio Price Target As It Awaits This
03:22pm, Tuesday, 19'th Jul 2022
RBC Capital Markets has lowered the price target on Inovio Pharmaceuticals Inc (NASDAQ: INO) to $4 from $5 with a Sector Perform rating. The analysts updated the model to reflect the evolution of
